ALS drug will be pulled from US market after study showed patients didn't benefit

https://www.msn.com/en-us/health/oth...D=ansmsnnews11

Although this company is nearby, I was surprised at the quick preliminary approval . . . I didn't follow the intervention's development but had noticed a number of patients reported adverse side effects. Practically every molecule has failed in full scale clinical study. Too bad the severity of the syndrome is unhelpful.